Utah Medical Products, Inc. (FRA:UTM)

Market Cap	206.51M +28.0%
Revenue (ttm)	32.55M -4.4%
Net Income	9.41M -16.3%
EPS	2.93 -10.6%
Shares Out	n/a
PE Ratio	21.95
Forward PE	n/a
Dividend	1.06 (1.89%)
Ex-Dividend Date	Jun 17, 2026

Volume	n/a
Open	56.00
Previous Close	57.00
Day's Range	56.00 - 56.00
52-Week Range	45.60 - 60.50
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 24, 2026

About Utah Medical Products

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1978
• Employees: 146
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UTM

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error